Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition
Hiroyuki Mori, … , Andy Greenfield, Ormond A. MacDougald
Hiroyuki Mori, … , Andy Greenfield, Ormond A. MacDougald
Published June 25, 2012
Citation Information: J Clin Invest. 2012;122(7):2405-2416. https://doi.org/10.1172/JCI63604.
View: Text | PDF
Research Article

Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition

  • Text
  • PDF
Abstract

Preadipocytes secrete several WNT family proteins that act through autocrine/paracrine mechanisms to inhibit adipogenesis. The activity of WNT ligands is often decreased by secreted frizzled-related proteins (SFRPs). Sfrp5 is strongly induced during adipocyte differentiation and increases in adipocytes during obesity, presumably to counteract WNT signaling. We tested the hypothesis that obesity-induced Sfrp5 expression promotes the development of new adipocytes by inhibiting endogenous suppressors of adipogenesis. As predicted, mice that lack functional SFRP5 were resistant to diet-induced obesity. However, counter to our hypothesis, we found that adipose tissue of SFRP5-deficient mice had similar numbers of adipocytes, but a reduction in large adipocytes. Transplantation of adipose tissue from SFRP5-deficient mice into leptin receptor–deficient mice indicated that the effects of SFRP5 deficiency are tissue-autonomous. Mitochondrial gene expression was increased in adipose tissue and cultured adipocytes from SFRP5-deficient mice. In adipocytes, lack of SFRP5 stimulated oxidative capacity through increased mitochondrial activity, which was mediated in part by PGC1α and mitochondrial transcription factor A. WNT3a also increased oxygen consumption and the expression of mitochondrial genes. Thus, our findings support a model of adipogenesis in which SFRP5 inhibits WNT signaling to suppress oxidative metabolism and stimulate adipocyte growth during obesity.

Authors

Hiroyuki Mori, Tyler C. Prestwich, Michael A. Reid, Kenneth A. Longo, Isabelle Gerin, William P. Cawthorn, Vedrana S. Susulic, Venkatesh Krishnan, Andy Greenfield, Ormond A. MacDougald

×

Figure 2

Characterization of Sfrp5Q27stop mutant mice.

Options: View larger image (or click on image) Download as PowerPoint
Characterization of Sfrp5Q27stop mutant mice.
 
(A) SFRP5 protein was de...
(A) SFRP5 protein was detected in eWAT of HFD-fed control mice, but not eWAT of NCD-fed control or Sfrp5Q27stop mice. Mice were fed HFD for 12 weeks, starting at 8 weeks of age. HEK 293T cells transfected with Sfrp5-Myc fusion construct served as a positive control. (B and C) Decreased Sfrp5 mRNA in Sfrp5Q27stop eWAT might be caused by elevated Wnt signaling. (B) Sfrp5 mRNA expression in eWAT from HFD-fed control or Sfrp5Q27stop mice, normalized to Tbp mRNA and expressed relative to controls (n = 17 per group). (C) EMSC adipocytes (day 12) were treated with vehicle or recombinant WNT3a (100 ng/ml) for 48 hours. Sfrp5 mRNA expression was normalized to Tbp and expressed relative to vehicle. (D) Sfrp5Q27stop mice resisted diet-induced weight gain. Body weight in mice from 4 to 20 weeks of age (n = 14–19). HFD was started at 8 weeks of age. (E) Decreased fat mass in Sfrp5Q27stop mice at 20 weeks of age (n = 8). (F) Reduced weight of WAT depots in female Sfrp5Q27stop mice at 20 weeks of age (n = 6–7). (G) Decreased weight of adipose tissue in Sfrp5Q27stop mice was due to reduced adipocyte size. H&E-stained gWAT samples from 20-week-old female mice were evaluated by histomorphometry, and the frequency of adipocyte sizes was plotted. For B–G, data are average ± SEM. *P < 0.05; **P < 0.01.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts